Peptic Ulcer Ayurvedic Treatment: Natural Ways to Heal Stomach Ulcers

Peptic ulcer is an open sore that develops on the inner lining of your stomach, the upper part of your small intestine (duodenum), or, less commonly, the lower esophagus. It happens when the protective mucous layer that shields your digestive tract from acidic juices breaks down, allowing stomach acid to erode the tissue beneath. The lifetime risk of developing a peptic ulcer is estimated at 5–10% globally, and while the condition has become less common over the past few decades thanks to better treatments, it still affects millions of people every year — particularly in developing countries including India.

If left untreated, peptic ulcers can lead to serious complications like internal bleeding, perforation of the stomach wall, and gastric outlet obstruction. The good news? Most peptic ulcers heal completely with the right medical treatment, and understanding the causes, symptoms, and modern treatment protocols puts you in a strong position to manage this condition effectively.

What Is Peptic Ulcer Disease?

Peptic ulcer disease (PUD) refers to a group of ulcerative conditions affecting the gastrointestinal tract, primarily driven by an imbalance between aggressive factors (stomach acid, pepsin, bile salts) and the defensive mechanisms that protect the mucosal lining (mucus secretion, bicarbonate buffering, epithelial cell renewal, and adequate blood flow).

• Under normal circumstances, the stomach lining produces a thick layer of mucus and bicarbonate ions that act as a barrier against hydrochloric acid.
• When this barrier is compromised — whether by bacterial infection, medication use, or other factors — acid penetrates the mucosa and causes tissue damage that can extend deep into the muscularis mucosa or even beyond.

Types of Peptic Ulcers

The Johnson classification further categorizes gastric ulcers into five types based on location and acid-secretion status:

• Type I — Lesser curvature of the stomach body (most common gastric ulcer; normal/low acid secretion)
• Type II — Gastric body + duodenal ulcer (associated with high acid secretion)
• Type III — Prepyloric region (associated with high acid secretion)
• Type IV — High on the lesser curvature near the gastroesophageal junction
• Type V — Anywhere in the stomach, associated with NSAID use (can be multiple)

What Causes Peptic Ulcers?

Contrary to what many people still beleive, stress and spicy food do not cause peptic ulcers — though they can aggravate symptoms. The two primary causes account for the vast majority of cases.

H. pylori Infection: The Leading Cause

Helicobacter pylori is a spiral-shaped, gram-negative bacterium that colonizes the gastric epithelium. It is the single most important cause of peptic ulcer disease worldwide. In India, H. pylori prevalence is estimated at 60–70% of the adult population, though not everyone infected develops ulcers. How H. pylori damages the stomach lining:

H. pylori possesses several virulence factors that allow it to survive in the acidic gastric environment and cause tissue damage:

• Urease enzyme — Converts urea into ammonia and carbon dioxide, creating a local alkaline microenvironment that protects the bacterium from stomach acid. However, the ammonia itself is toxic to epithelial cells.
• CagA (cytotoxin-associated gene A) — A protein injected directly into gastric epithelial cells that disrupts cell signaling, promotes inflammation, and is strongly linked to a higher risk of gastric cancer.
• VacA (vacuolating cytotoxin A) — Forms pores in epithelial cell membranes, induces cell apoptosis, and suppresses local immune responses.
• Flagella — Enable the bacterium to move through the viscous mucus layer to reach the epithelial surface.
• Adhesins — Surface proteins (like BabA and SabA) that allow H. pylori to bind tightly to gastric cells.

The chronic inflammation triggered by H. pylori weakens the mucosal defense system, making the tissue vulnerable to acid-peptic digestion. Importantly, H. pylori infection is also classified by the WHO as a Group 1 carcinogen — it significantly increases the risk of gastric adenocarcinoma and MALT lymphoma.

NSAIDs: The Second Major Cause

Nonsteroidal anti-inflammatory drugs (ibuprofen, aspirin, naproxen, diclofenac) are the second most common cause of peptic ulcers. These medications work by blocking cyclooxygenase (COX) enzymes — specifically COX-1 and COX-2. While COX-2 inhibition provides pain relief and reduces inflammation, COX-1 inhibition simultaneously reduces the production of prostaglandins that are essential for maintaining gastric mucosal blood flow, mucus secretion, and bicarbonate production.

The result: a weakened mucosal barrier that's vulnerable to acid-peptic injury.

Other Causes

• Zollinger-Ellison syndrome — A rare condition involving gastrin-secreting tumors (gastrinomas) that cause massive acid hypersecretion
• Crohn's disease — Can cause ulceration anywhere in the GI tract
• Hypersecretory conditions — Systemic mastocytosis, hyperparathyroidism, cystic fibrosis, antral G-cell hyperplasia
• Radiation or chemotherapy
• Severe physiological stress — Major burns (Curling's ulcers), head injuries (Cushing's ulcers), critical illness
• Other infections — Rare in immunocompetent individuals but seen in immunocompromised patients (CMV, HSV)

What Are the Signs and Symptoms of a Peptic Ulcer?

The most common symptom of a peptic ulcer is a burning or gnawing epigastric pain — often described as a dull ache in the upper abdomen, between the navel and the breastbone. But the presentation can vary considerably depending on the ulcer's location and severity.

Common Symptoms

• Epigastric pain — The hallmark symptom. May be worse on an empty stomach or at night.
• Bloating and abdominal fullness
• Nausea, sometimes with vomiting
• Heartburn or acid reflux
• Loss of appetite and unintended weight loss
• Feeling hungry shortly after eating (especially with duodenal ulcers)
• Belching

Gastric vs Duodenal Ulcer Symptoms: Key Differences

Alarm Symptoms — When Should You See a Doctor?

Seek immediate medical attention if you experience any of the following:

• Vomiting blood (hematemesis) — may appear bright red or look like coffee grounds
• Dark, tarry, or black stools (melena) — indicates bleeding in the upper GI tract
• Sudden, severe, sharp abdominal pain — could indicate perforation
• Unexplained weight loss
• Difficulty swallowing (dysphagia)
• Persistent vomiting or inability to keep food down — could suggest gastric outlet obstruction
• Signs of anemia — fatigue, pallor, shortness of breath, dizziness

These symptoms may indicate life-threatening complications that require emergency treatment.

How Are Peptic Ulcers Diagnosed?

Diagnosis of peptic ulcers follows a systematic approach that typically begins with testing for H. pylori and progresses to endoscopy when indicated.

Step-by-Step Diagnostic Algorithm

Step 1: Clinical Assessment

History of epigastric pain, NSAID use, smoking, family history of PUD. Patients under 60 with typical symptoms and no alarm features may be initially tested for H. pylori without endoscopy.

Step 2: Testing for H. pylori

• | Blood antibody test | Non-invasive | 85–95% | 79–90% | Detects IgG antibodies.
• Cannot distinguish between active and past infection — not recommended for confirming eradication. |

> Important: PPIs should be stopped at least 1–2 weeks, and antibiotics at least 4 weeks, before H. pylori testing to avoid false-negative results.

Step 3: Upper Endoscopy (Esophagogastroduodenoscopy — EGD)

• The definitive diagnostic procedure. A thin, flexible tube with a camera is inserted through the mouth to directly visualize the ulcer.
• Biopsies can be taken to:
• Test for H. pylori (rapid urease test, histology, culture)
• Rule out gastric cancer (all gastric ulcers should be biopsied)

Endoscopy is recommended for patients with alarm symptoms, patients over 60, those who fail initial empiric therapy, and those with recurrent symptoms.

Step 4: Upper GI Series (Barium Swallow)

An alternative when endoscopy is unavailable or contraindicated. Less sensitive and doesn't allow biopsy. The patient swallows a barium contrast solution, and X-rays reveal ulcer craters.

Step 5: Additional Investigations

• CT scan — if perforation or other complications are suspected
• Fasting serum gastrin level — if Zollinger-Ellison syndrome is suspected (gastrin >1000 pg/mL is highly suggestive)

Forrest Classification for Bleeding Ulcers

When a bleeding ulcer is found during endoscopy, the Forrest classification guides treatment decisions:

How to Heal a Peptic Ulcer: Treatment Options

• Treatment of peptic ulcers depends on the underlying cause.
• The goals are straightforward: eliminate the cause (eradicate H. pylori or stop NSAIDs), reduce stomach acid to allow healing, protect the mucosal lining, and treat complications.

H. pylori Eradication Therapy — Specific Protocols with Dosages

This is one of the most critical aspects of PUD treatment, yet it's often poorly explained. Here are the standard regimens recommended by the American College of Gastroenterology (ACG) and the Maastricht V/Florence Consensus:

First-Line: Standard Triple Therapy (14 days)

• PPI (e.g., omeprazole 20 mg or esomeprazole 40 mg) — twice daily
• Clarithromycin 500 mg — twice daily
• Amoxicillin 1000 mg — twice daily

OR (if penicillin-allergic):

• PPI + Clarithromycin 500 mg + Metronidazole 500 mg — all twice daily for 14 days

> Note: This regimen is recommended only in areas where clarithromycin resistance is below 15%. In many parts of India, clarithromycin resistance rates exceed 20%, making this regimen less reliable.

First-Line Alternative: Bismuth Quadruple Therapy (14 days)

• PPI — twice daily
• Bismuth subsalicylate 524 mg — four times daily
• Metronidazole 250 mg — four times daily
• Tetracycline 500 mg — four times daily

This is preferred in areas with high clarithromycin resistance.

Concomitant Therapy (Non-Bismuth Quadruple, 14 days)

• PPI — twice daily
• Clarithromycin 500 mg — twice daily
• Amoxicillin 1000 mg — twice daily
• Metronidazole 500 mg — twice daily

Studies show eradication rates of 85–90% with this regimen, even in areas with moderate clarithromycin resistance.

Rescue/Third-Line: Levofloxacin-Based Triple Therapy (14 days)

• PPI — twice daily
• Levofloxacin 500 mg — once daily
• Amoxicillin 1000 mg — twice daily

Used after failure of first-line therapy. Fluoroquinolone resistance is rising, so culture-guided therapy is preferred when available.

Antibiotic Resistance — A Growing Concern

• H. pylori antibiotic resistance is a significant global problem.
• A 2019 systematic review published in Gut found that:

• Clarithromycin resistance is approximately 15–30% in many Asian countries, including parts of India
• Metronidazole resistance can exceed 40% in South Asia
• Amoxicillin resistance remains low (<5% globally)
• Levofloxacin resistance is increasing, particularly in Asia (15–30%)

Clinical implication: Clinicians in India should strongly consider bismuth quadruple therapy or concomitant therapy as first-line rather than standard triple therapy, given local resistance patterns. When possible, culture and sensitivity testing after first-line failure is ideal.

Acid-Suppression Medications

Comparison of Proton Pump Inhibitors (PPIs)

PPIs are the cornerstone of acid suppression. They irreversibly inhibit the H+/K+ ATPase proton pump on gastric parietal cells. For uncomplicated duodenal ulcers, PPIs are typically prescribed for 4–8 weeks. For gastric ulcers, 8–12 weeks is standard because gastric ulcers heal more slowly.

H2-Receptor Antagonists

Ranitidine (withdrawn in many countries due to NDMA contamination), famotidine (20–40 mg twice daily), and cimetidine are less potent than PPIs but can be used as adjuncts or when PPIs are not tolerated.

Cytoprotective Agents

• Sucralfate — Binds to ulcer base and forms a protective barrier; particularly useful for stress ulcer prophylaxis
• Misoprostol — A prostaglandin analog that enhances mucosal defense; specifically used to prevent NSAID-induced ulcers (but contraindicated in pregnancy due to abortifacient properties)
• Bismuth compounds — Have antibacterial properties against H. pylori and form a protective coat over the ulcer

Surgical and Endoscopic Treatment

Surgery for peptic ulcers has become uncommon thanks to effective medical therapy, but it is still necessary in certain situations:

• Endoscopic hemostasis — For actively bleeding ulcers (Forrest Ia, Ib, IIa): includes injection therapy (epinephrine), thermal coagulation, and hemoclip placement
• Angiographic embolization — When endoscopic treatment fails to control bleeding
• Vagotomy — Cutting branches of the vagus nerve to reduce acid secretion (highly selective vagotomy preserves gastric motility)
• Pyloroplasty — Widening the pyloric sphincter, often combined with vagotomy
• Partial gastrectomy — Removal of the ulcer-bearing portion of the stomach; reserved for refractory or malignant ulcers
• Emergency surgery for perforation — Simple closure (Graham patch) with omental reinforcement

Do Peptic Ulcers Go Away on Their Own?

In rare cases, very small ulcers might heal spontaneously — but relying on this is risky. Without treating the underlying cause (particularly H. pylori), the recurrence rate is extremely high: up to 60–80% within one year for duodenal ulcers and 40–60% for gastric ulcers. With successful H. pylori eradication, the annual recurrence rate drops to less than 5%.

Prognosis and Post-Treatment Monitoring

Most uncomplicated peptic ulcers heal within 4–8 weeks of starting appropriate therapy.

Here's what follow-up should look like:

• Confirm H. pylori eradication: Perform a urea breath test or stool antigen test at least 4 weeks after completing antibiotics AND at least 1–2 weeks after stopping PPIs to avoid false negatives
• Follow-up endoscopy for gastric ulcers: Recommended 8–12 weeks after treatment to confirm healing and rule out malignancy (repeat biopsy)
• Duodenal ulcers: Follow-up endoscopy is generally not required unless symptoms persist
• Complicated ulcers (bleeding, perforation): Closer monitoring; repeat endoscopy is usually warranted

How to Prevent Peptic Ulcers

Prevention revolves around addressing the known risk factors.

For H. pylori–Related Ulcers

• Test-and-treat strategy for symptomatic individuals, especially in high-prevalence regions like India
• Improved sanitation and hygiene (H. pylori spreads via fecal-oral and oral-oral routes)

For NSAID-Related Ulcers

• Use the lowest effective dose of NSAIDs for the shortest possible duration
• Co-prescribe a PPI if long-term NSAID use is unavoidable
• Consider using COX-2 selective inhibitors (celecoxib) instead of non-selective NSAIDs — they carry a lower GI risk
• Misoprostol co-therapy as an alternative gastroprotective strategy

Managing Anticoagulant and Antiplatelet Risks

• Patients on dual antiplatelet therapy (aspirin + clopidogrel) or anticoagulants (warfarin, DOACs) face a heightened risk of GI bleeding from peptic ulcers.
• Key strategies include:

• Co-prescribe a PPI (pantoprazole preferred with clopidogrel due to fewer CYP2C19 interactions)
• Test and treat H. pylori before starting long-term antithrombotic therapy
• Regular monitoring for signs of GI bleeding (check stools, hemoglobin levels)

General Lifestyle Measures

• Stop smoking — Smoking impairs ulcer healing, increases recurrence, and raises complication risk
• Limit alcohol — Alcohol irritates the gastric mucosa and increases acid secretion
• Diet: While food does not cause ulcers, spicy, acidic, and fried foods can aggravate symptoms. Eating smaller, more frequent meals may help some patients
• Stress management — While psychological stress alone doesn't cause ulcers, it can worsen symtoms and delay healing

Special Populations: PUD in Pregnancy, Children, and the Elderly

Peptic Ulcers During Pregnancy

• PUD in pregnancy is uncommon — elevated progesterone actually reduces gastric acid secretion
• PPIs: Omeprazole, lansoprazole, and pantoprazole are classified as generally compatible with pregnancy (though older FDA Category B/C labels existed, current evidence supports reasonable safety). Omeprazole has the most human data.
• H2 blockers: Ranitidine (if available) and famotidine are considered safe alternatives
• NSAIDs: Absolutely contraindicated in the third trimester (risk of premature closure of the ductus arteriosus) and best avoided throughout pregnancy
• Antibiotics for H. pylori: Eradication therapy is generally deferred until after delivery, unless clinically urgent. Metronidazole and clarithromycin have limited safety data in pregnancy; amoxicillin is preferred if treatment is necessary
• Misoprostol: Strictly contraindicated — causes uterine contractions

Peptic Ulcers in Children

• Less common than in adults; H. pylori infection and NSAID use remain the primary causes
• Symptoms may be atypical — young children often present with vague abdominal pain, feeding difficulties, or vomiting rather than classic epigastric burning
• Diagnosis relies on endoscopy; non-invasive H. pylori testing is preferred for initial evaluation
• Treatment follows the same principles as adults, with weight-based dosing for PPIs and antibiotics

Peptic Ulcers in the Elderly

• Older adults are at significantly higher risk due to frequent NSAID/aspirin use, polypharmacy, and reduced mucosal defense with aging
• Symptoms are often less pronounced or atypical — many elderly patients present with complications (bleeding, perforation) as the first sign
• Gastric ulcers in the elderly always require biopsy to exclude malignancy
• Drug interactions must be carefully assessed when prescribing PPIs or antibiotics alongside existing medications

Complications of Peptic Ulcer Disease

Without proper treatment, peptic ulcers can cause severe, potentially life-threatening complications:

• 1.Gastrointestinal bleeding — The most common complication. Occurs when the ulcer erodes into a blood vessel. Mortality from bleeding ulcers remains approximately 5–10%.
• 2.Perforation — The ulcer erodes through the full thickness of the stomach or duodenal wall, causing peritonitis. This is a surgical emergency with mortality rates of 5–25%.
• 3.Gastric outlet obstruction — Chronic inflammation and scarring near the pylorus can narrow the gastric outlet, causing recurrent vomiting, early satiety, and weight loss. Accounts for about 5–8% of ulcer complications.
• 4.Penetration — The ulcer erodes into an adjacent organ (e.g., pancreas, liver) without free perforation into the peritoneal cavity.
• 5.Gastric cancer — Long-standing H. pylori infection increases the risk of gastric adenocarcinoma by 2–6 fold.

Differential Diagnosis: What Else Could It Be?

Several conditions can mimic peptic ulcer symptoms and should be ruled out:

• Gastroesophageal reflux disease (GERD)
• Functional dyspepsia
• Gastric cancer
• Pancreatitis
• Biliary colic (gallstones)
• Mesenteric ischemia
• Crohn's disease of the upper GI tract
• Gastroparesis
• Cardiac ischemia (inferior MI can present as epigastric pain)

Frequently Asked Questions (FAQ)

Should I adjust my diet while living with peptic ulcer disease?

• Food does not cause peptic ulcers, but certain dietary choices can influence symptom severity.
• Avoid foods that worsen your individual symptoms — commonly citrus fruits, tomato-based products, spicy dishes, caffeine, and carbonated drinks. There's no single "ulcer diet" that works for everyone. Small, regular meals may reduce symptoms for some people.
• Importantly, do not rely on dietary changes alone — treating the underlying cause (H. pylori eradication or stopping NSAIDs) is essential.

Can peptic ulcer disease be prevented completely?

Not in all cases, but risk can be dramatically reduced. Eradicating H. pylori in infected individuals, using gastroprotective agents when taking NSAIDs, quitting smoking, and moderating alcohol intake are the most effective preventive strategies. In high-risk populations (such as patients starting long-term NSAID or antiplatelet therapy), proactive screening and prophylactic PPI use are recommended.

What is the prognosis after treatment for peptic ulcer disease?

The prognosis is excellent for most patients. With successful H. pylori eradication, more than 95% of duodenal ulcers and approximately 85–90% of gastric ulcers heal completely. Annual recurrence after successful eradication is less than 5%, compared to 60–80% without eradication. Patients with complicated ulcers (bleeding or perforation) generally have good outcomes with prompt treatment, though they require closer follow-up.

How long does it take for a peptic ulcer to heal?

Duodenal ulcers typically heal in 4–6 weeks with PPI therapy. Gastric ulcers generally take 8–12 weeks. Factors that can delay healing include continued smoking, ongoing NSAID use, large ulcer size, and failure to eradicate H. pylori.

Is there a link between peptic ulcers and stomach cancer?

• Yes, but indirectly.
• H. pylori — the most common cause of peptic ulcers — is a recognized carcinogen. Chronic H. pylori infection increases the risk of gastric adenocarcinoma by 2–6 times and is also linked to gastric MALT lymphoma. This is one more reason why H. pylori eradication is so important, even when ulcer symptoms are mild.

Final Thoughts

Peptic ulcer disease is a well-understood condition with highly effective treatments available today. Whether your ulcer is caused by H. pylori infection, NSAID use, or another factor, the path to healing starts with an accurate diagnosis and the right treatment protocol.

Don't ignore persistent stomach pain, especially if it worsens at night or is accompanied by any alarm symptoms like vomiting blood or dark stools. Early diagnosis and treatment can prevent serious complications and, quite literally, save your life.

If you're experiencing symptoms suggestive of a peptic ulcer, consult a gastroenterologist. Ask for H. pylori testing, discuss your NSAID use, and follow through with the full course of prescribed treatment. Your gut will thank you for it.

Scientific Sources

1. Helicobacter pylori infection: a dynamic process from diagnosis to treatment — Sun Q et al., 2023, Frontiers in cellular and infection microbiology
2. Traditional uses, bioactive composition, pharmacology, and toxicology of Phyllanthus emblica fruits: A comprehensive review — Saini R et al., 2022, Journal of ethnopharmacology
3. Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds — Asl MN et al., 2008, Phytotherapy research : PTR
4. All you need to know about gastrinoma today | Gastrinoma and Zollinger-Ellison syndrome: A thorough update — Chatzipanagiotou O et al., 2023, Journal of neuroendocrinology
5. Antimuscarinic drugs — Stockbrügger RW, 1989, Methods and findings in experimental and clinical pharmacology
6. A Review on Herbal Drugs Used in the Treatment of Peptic Ulcer — Roy AJ et al., 2023, Current drug discovery technologies
7. Secondary metabolites for antiulcer activity — Jain P, 2016, Natural product research
8. Treatment of gastric ulcer, traditional Chinese medicine may be a better choice — Gong H et al., 2024, Journal of ethnopharmacology
9. Peptic Ulcer Disease: A Brief Review of Conventional Therapy and Herbal Treatment Options — Kuna L et al., 2019, Journal of clinical medicine
10. Plants with Anti-Ulcer Activity and Mechanism: A Review of Preclinical and Clinical Studies — Prayoga DK et al., 2024, Drug design, development and therapy
11. Spices, herbal xenobiotics and the stomach: friends or foes? — Al Mofleh IA, 2010, World journal of gastroenterology
12. The calcium-alkali syndrome — Arroyo M et al., 2013, Proceedings (Baylor University. Medical Center)
13. Research progress of potassium-competitive acid blockers in the treatment of Helicobacter pylori — Ma Z et al., 2025, Annals of medicine
14. Clinical efficacy and mechanism of Bletilla striata and Chinese herbal compounds in treatment of peptic ulcer — Sun YT et al., 2025, World journal of gastroenterology
15. Peptic Ulcer Disease: A Comprehensive Review on Conventional Therapy and Herbal Treatment — Kumar V et al., 2025, Current drug discovery technologies
16. Gastroduodenal safety of cyclooxygenase-2 inhibitors — Scheiman JM, 2003, Current pharmaceutical design
17. Scientific evaluation of edible fruits and spices used for the treatment of peptic ulcer in traditional Iranian medicine — Farzaei MH et al., 2013, ISRN gastroenterology
18. Astible Rivularis: Bioactive Compounds and Pharmacological Functions — Timalsena S et al., 2019, Chinese journal of integrative medicine
19. Genetic liability to obesity and peptic ulcer disease: a Mendelian randomization study — Li Z et al., 2022, BMC medical genomics
20. Analgesic and anti-inflammatory activities of NPK 500 capsules, a Cassia sieberiana DC. - Based herbal analgesic medicine used to treat dysmenorrhea and peptic ulcer, is mediated through the inhibition of PGE2 and iNOS — Kumatia EK et al., 2024, Journal of ethnopharmacology